Wednesday, December 08, 2021

NEWS

AstraZeneca’s COVID-19 vaccine is now called Vaxzevria

AstraZeneca’s COVID-19 vaccine is now called Vaxzevria

London, Mar 30 (Prensa Latina) The Covid-19 vaccine developed by the Anglo-Swedish pharmaceutical AstraZeneca and the British University of Oxford had its name changed to Vaxzevria, Russia Today reported on Tuesday.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

At the request of the company, the new name was approved by the European Medicines Agency.

‘The change in the name is not associated with any other change in the drug, but underlines the importance that those responsible for vaccination are aware of it, since the information on the product, labeling and packaging may have a different appearance,’ the source noted.

The World Health Organization (WHO) said recently that it would review reports on the suspension of the AstraZeneca vaccine in several countries.

Denmark, Thailand, Norway and Iceland suspended vaccination with that vaccine, while Austria, Estonia, Latvia, Lithuania, Luxembourg and Italy stopped using some batches of it.

Those countries’ decision came, for the most part, following reports of blood clots in people who had been administered the vaccine.

That same batch was distributed in 17 countries, among them Spain, where so far no cases like these have been reported, only minor side effects.

The WHO stressed that it is studying the situation of the AstraZeneca vaccine and the results will be publicly disclosed with their respective recommendations.

jg/llp/mem/joe

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.